Larry E. Fields

3.3k citations

31 papers · 2.7k indexed · 2 hit papers · h-index 17

Impact in

Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 1%
- Blood Pressure and Hypertension Studies
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments

Papers in ⓘ

Internal Medicine 7
- Venous Thromboembolism Diagnosis and Management 7
Cardiology and Cardiovascular Medicine 19
- Atrial Fibrillation Management and Outcomes 12
- Cardiac Arrhythmias and Treatments 5
- Antiplatelet Therapy and Cardiovascular Diseases 5
- Acute Myocardial Infarction Research 4
- Cardiac electrophysiology and arrhythmias 3

Co-authors: Edward J. Roccella (2 shared papers)Paul D. Sorlie (2 shared papers)Thomas Thom (1 shared paper)Jeffrey A. Cutler (1 shared paper)Michael Wolz (1 shared paper)Vicki L. Burt (1 shared paper)Dennis Y. Loh (5 shared papers)Keiko Nakayama (2 shared papers)
Journals: Hypertension (2 papers)The Journal of Immunology (2 papers)Current Medical Research and Opinion (2 papers)Proceedings of the National Academy of Sciences (2 papers)Blood (1 paper)
Partner nations: United States Belgium Cyprus

In The Last Decade

Larry E. Fields

30 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988–1994 and 1999–2004 2008 · 704 citations

Peers

Countries citing papers authored by Larry E. Fields

Since Specialization

Citations

This map shows the geographic impact of Larry E. Fields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry E. Fields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry E. Fields more than expected).

Fields of papers citing papers by Larry E. Fields

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry E. Fields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry E. Fields. The network helps show where Larry E. Fields may publish in the future.

Co-authors

The 25 scholars most cited alongside Larry E. Fields, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Larry E. Fields Line = papers co-authored together Larry E. Fields links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988–1994 and 1999–2004 Hypertension ·Jeffrey A. Cutler, Paul D. Sorlie, Michael Wolz, Thomas Thom, Larry E. Fields, Edward J. Roccella Hit paper breakdown →	2008	704
2	The Burden of Adult Hypertension in the United States 1999 to 2000 Hypertension ·Larry E. Fields, Vicki L. Burt, Jeffery A. Cutler, Jeffrey Hughes, Edward J. Roccella, Paul D. Sorlie Hit paper breakdown →	2004	698
3	Disappearance of the Lymphoid System in Bcl-2 Homozygous Mutant Chimeric Mice Science ·Kei-ichi Nakayama, Keiko Nakayama, Izumi Negishi, Keisuke Kuida, Yoichi Shinkai, Marjorie C. Louie, Larry E. Fields, Phillip J. Lucas, Valerie Stewart, Frederick W. Alt, Dennis Y. Loh	1993	360
4	Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. The Journal of Immunology ·Philip J. Lucas, Izumi Negishi, Keiko Nakayama, Larry E. Fields, Dennis Y. Loh	1995	192
5	Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban Clinical Cardiology ·Sally Tamayo, W. Frank Peacock, Manesh R. Patel, Nicholas Sicignano, K Hopf, Larry E. Fields, Troy C. Sarich, Shujian Wu, Daniel Yannicelli, Žhong Yuan	2015	127
6	Mutations of the chloramphenicol acetyl transferase transgene driven by the immunoglobulin promoter and intron enhancer International Immunology ·Takachika Azuma, Noboru Motoyama, Larry E. Fields, Dennis Y. Loh	1993	66
7	Expression of Janus Kinase 3 in Human Endothelial and Other Non-lymphoid and Non-myeloid Cells Journal of Biological Chemistry ·James Verbsky, Erika A Bach, Yifu Fang, Liping Yang, David A. Randolph, Larry E. Fields	1996	64
8	One-Year Adherence to Warfarin Treatment for Venous Thromboembolism in High-Risk Patients and Its Association with Long-term Risk of Recurrent Events Journal of Managed Care Pharmacy ·Shih‐Yin Chen, Ning Wu, Michael P. Gulseth, Joyce LaMori, Brahim Bookhart, Luke Boulanger, Larry E. Fields, Jeff Schein	2013	50
9	Impact of Co-morbidities and Patient Characteristics on International Normalized Ratio Control Over Time in Patients With Nonvalvular Atrial Fibrillation The American Journal of Cardiology ·Winnie W. Nelson, Jiyoon Choi, Julie Vanderpoel, Chandrasekharra V. Damaraju, Peter Wildgoose, Larry E. Fields, Jeffrey Schein	2013	48
10	Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke International Journal of Cardiology ·Mark J. Alberts, W. Frank Peacock, Larry E. Fields, Thomas J. Bunz, Elaine Nguyen, Dejan Milentijevic, Jeff Schein, Craig I Coleman	2016	47
11	Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population Thrombosis Research ·Charles E. Mahan, Maxine D. Fisher, Roger M. Mills, Larry E. Fields, Judith J. Stephenson, An-Chen Fu, Alex C. Spyropoulos	2013	44
12	Dysregulated Myelopoiesis in Mice Lacking Jak3 Blood ·William J. Grossman, James Verbsky, Liping Yang, Leslie J. Berg, Larry E. Fields, David Chaplin, Lee Ratner	1999	42
13	Organ injury associated with extrathymic induction of immune tolerance in doubly transgenic mice. Proceedings of the National Academy of Sciences ·Larry E. Fields, Dennis Y. Loh	1992	33
14	Rivaroxaban crushed tablet suspension characteristics and relative bioavailability in healthy adults when administered orally or via nasogastric tube Clinical Pharmacology in Drug Development ·Kenneth Todd Moore, Mark A. Krook, Seema Vaidyanathan, Troy C. Sarich, C. V. Damaraju, Larry E. Fields	2014	32
15	International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation American Journal of Cardiovascular Drugs ·Winnie W. Nelson, Sunita Desai, C. V. Damaraju, Lang Lu, Larry E. Fields, Peter Wildgoose, Jeffery R. Schein	2015	32
16	Doses of apixaban and rivaroxaban prescribed in real-world United States cardiology practices compared to registration trials Current Medical Research and Opinion ·Elaine Nguyen, C Michael White, Manesh R. Patel, Larry E. Fields, W. Frank Peacock, Concetta Crivera, Craig I Coleman	2016	25
17	Coronary thrombolysis with facilitated absorption of intramuscularly injected tissue-type plasminogen activator. Proceedings of the National Academy of Sciences ·Burton E. Sobel, Larry E. Fields, Alice K. Robison, Keith A.A. Fox, Stanley J. Sarnoff	1985	23
18	Effect of fatty acid on performance and lipid content of hearts from diabetic rabbits American Journal of Physiology-Heart and Circulatory Physiology ·Larry E. Fields, Alan Daugherty, Steven R. Bergmann	1986	15
19	Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation Journal of Interventional Cardiac Electrophysiology ·(unknown), Gerald V. Naccarelli, Riccardo Cappato, Stefan H. Hohnloser, Francis E. Marchlinski, David J. Wilber, Jim Xiang, Changsheng Ma, Susanne Hess, David Wyn Davies, Larry E. Fields, Andrea Natale	2014	13
20	International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation Current Medical Research and Opinion ·Winnie W. Nelson, Sunita Desai, C.V. Damaraju, Lang Lu, Larry E. Fields, Peter Wildgoose, Jeff Schein	2014	12

About Larry E. Fields

Larry E. Fields is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Immunology, Pharmacology and Nutrition and Dietetics, having authored 31 papers that have together received 2.7k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (12 papers), Venous Thromboembolism Diagnosis and Management (7 papers), Cardiac Arrhythmias and Treatments (5 papers), T-cell and B-cell Immunology (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Immune Cell Function and Interaction (4 papers), Acute Myocardial Infarction Research (4 papers) and Cardiac electrophysiology and arrhythmias (3 papers). The work is most often cited by research in Internal Medicine (269 citations), Cardiology and Cardiovascular Medicine (1.3k citations), Family Practice (87 citations), Immunology (530 citations) and Geriatrics and Gerontology (75 citations). Larry E. Fields has collaborated with scholars based in United States, Belgium and Cyprus. Frequent co-authors include Edward J. Roccella, Paul D. Sorlie, Thomas Thom, Jeffrey A. Cutler, Michael Wolz, Vicki L. Burt, Dennis Y. Loh, Keiko Nakayama, Izumi Negishi and Philip J. Lucas. Their work appears in journals such as Hypertension, The Journal of Immunology, Current Medical Research and Opinion, Proceedings of the National Academy of Sciences and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact